Overview

Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Digoxin and Rosuvastatin

Status:
COMPLETED
Trial end date:
2025-07-02
Target enrollment:
Participant gender:
Summary
Drug-drug interaction study between Bemnifosbuvir/Ruzasvir and Digoxin or Rosuvastatin
Phase:
PHASE1
Details
Lead Sponsor:
Atea Pharmaceuticals, Inc.
Treatments:
AT-511